Efficacy of zinc against common cold viruses: An overview

Journal of the American Pharmacists Association

Volumn 44, Issue 5, 2004, Pages 594-603

  Hulisz, Darrell ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

Common cold; Dietary supplements; Infectious diseases; Minerals; Vitamins; Zinc

Indexed keywords

GLUCONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; ZINC ACETATE;

CHEMISTRY; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HUMAN; PATHOGENICITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOVIRUS; TREATMENT OUTCOME;

CHEMISTRY, PHARMACEUTICAL; COMMON COLD; GLUCONATES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; RANDOMIZED CONTROLLED TRIALS; RHINOVIRUS; TREATMENT OUTCOME; ZINC ACETATE;

EID: 85047688280     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.44.5.594.Hulisz     Document Type: Review

References (32)

1. Farr BM, Conner EM, Betts RF, et al. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. 1987;31:1183-7.
2. Fendrick AM. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther. 2003;10:193-202.
3. Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361:51-9.
4. Merluzzi VJ, Cipriano D, McNeil D, et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Res Comm Chem Pathol Pharmacol. 1989;66:425-40.
5. Novick SG, Godfrey JC, Godfrey NJ, et al. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. Med Hypotheses. 1996;46:295-302.
6. Sugarman B. Zinc and infection. Rev Infect Dis. 1983;5:137-47.
7. Bashford CL, Alder GM, Graham JM, et al. Ion modulation of membrane permeability: effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. J Membrane Biol. 1988;103:79-94.
8. Bashford CL, Alder GM, Menestrina G, et al. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. J Biol Chem. 1986;261:9300-8.
9. Bashford CL, Menestrina G, Henkart PA, Pasternak CA. Cell damage by cytolysin. Spontaneous recovery and reversible inhibition by divalent cations. J Immunol. 1988;141:3965-74.
10. 2+. Bioassays. 1987;6:14-9.
11. Turner RB. The treatment of rhinovirus infections: progress and potential. Antiviral Res. 2001;49:1-14.
12. Novick SG, Godfrey JC, Pollack RL, et al. Zinc-induced suppression of inflammation in the respiratory tract, caused by infection with human rhinovirus and other irritants. Med Hypotheses. 1997;49:347-57.
13. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med. 1996;74:13-33.
14. Bella J, Kolatkar PR, Marlor CW, et al. The structure of the two aminoterminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA. 1998;95:4140-5.
15. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 2003;96:35-43.
16. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Ann Intern Med. 2000;133:245-52.
17. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25:20-4.
18. Mossad SB, Macknin ML, Medendorp SV, et al. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebocontrolled study. Ann Intern Med. 1996;125:81-8.
19. Al-Nakib W, Higgins PG, Barrow I, et al. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother. 1987;20:893-901.
20. Douglas RM, Miles HB, Moore BW, et al. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother. 1987;31:1263-5.
21. Smith DS, Helzner EC, Nuttall CE Jr, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother. 1989;33:646-8.
22. Weismann K, Jakobsen JP, Weismann JE, et al. Zinc gluconate lozenges for common cold. A double-blind clinical trial. Dan Med Bull. 1990;37:279-81.
23. Godfrey JC, Sloane BC, Smith DS, et al. Zinc gluconate and the common cold: a controlled clinical study. J Intern Med Res. 1992;20:234-46.
24. Petrus EJ, Lawson KA, Bucci LR, et al. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res. 1998;59:595-607.
25. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children. A randomized controlled trial. JAMA. 1998;279:1962-7.
26. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clin Infect Dis. 2000;31:1202-8.
27. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med. 2001;111:103-8.
28. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: a double-blind, placebo-controlled trial. Ear Nose Throat J. 2000;79:778-80,782.
29. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis. 2001;33:1865-70.
30. Jackson JL, Peterson C, Lesho E. A meta-analysis of zinc salts lozenges and the common cold. Arch Intern Med. 1997;157:2373-6.
31. Eby GA. Elimination of efficacy by additives in zinc acetate lozenges for common colds [letter]. Clin Infect Dis. 2001;32:1520.
32. Rutty CJ. The middle-class plague: epidemic polio and the Canadian State, 1936-1937. Canadian Bull Med Hist. 1996;13:277-314.